Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Pathology Lab Selects Intelligent Transport System for Automation Project

By LabMedica International staff writers
Posted on 30 May 2012
A 300-meter conveyor system is expected to double the processing capacity of a pathology lab.

ARUP Laboratories (Salt Lake City, UT, USA) an enterprise of the University of Utah and a national clinical and anatomic pathology reference laboratory, has chosen the MagneMover LITE (MM LITE) intelligent transport system, developed and produced by MagneMotion (Devens, MA, USA), to replace its existing automation system. More...


The approximately 300-meter long MM LITE conveyor system will utilize 500 MM LITE motors and will provide the speed and precision to double ARUP’s current throughput capacity for samples processed on a daily basis. MagneMotion has begun delivering key parts of the system, which is scheduled to be operational by 2014.

“ARUP has a vision for implementing best-in-class automation as part of this major lab upgrade at their campus in Salt Lake City. MagneMotion was thrilled to be chosen to provide a key element of that world-leading automation capability with our MagneMover LITE intelligent transport system,” stated Peter Mattila, MagneMotion VP of Sales and Marketing.

“MagneMotion’s MM LITE system is highly advanced,” stated Heidi Kildee, Project Manager, Automation Projects, ARUP Laboratories; “The systems speed, ease of use, and continuous tracking of samples were all factors that led to ARUP choosing this product. In addition, the modularity of [this] system gives us flexibility for future growth.”

Dr. Charles Hawker, Scientific Director, Automation and Special Projects, ARUP Laboratories, presented details of the new system at the eighth Cherry Blossom Symposium on Clinical Laboratory Automation in Seoul (South Korea) on April 12, 2012.

Related Links:

ARUP Laboratories
MagneMotion Inc.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.